Widespread Gaps in Alzheimer’s Infusion Therapy Adoption Highlight Access Challenges
The introduction of lecanemab, a new infusion therapy for Alzheimer’s disease (AD), has unveiled stark disparities in access and adoption ...
The introduction of lecanemab, a new infusion therapy for Alzheimer’s disease (AD), has unveiled stark disparities in access and adoption ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine